Making Sense of Weight-Loss Drugs’ Cost and Coverage

WSJ Your Money Briefing

GLP-1s like Ozempic and Wegovy are no longer in short supply, yet they still can cost more than $1,000 a month out of pocket. Wall Street Journal contributor Cheryl Winokur Munk joins host Callum Borchers to dig into why some people pay much more for weight-loss drugs than others. 


Sign up for the WSJ's free Markets A.M. newsletter


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More description

GLP-1s like Ozempic and Wegovy are no longer in short supply, yet they still can cost more than $1,000 a month out of pocket. Wall Street Journal contributor Cheryl Winokur Munk joins host Callum Borchers to dig into why some people pay much more for weight-loss drugs than others. 


Sign up for the WSJ's free Markets A.M. newsletter


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

2025-06-04 6 min
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in

Chapters

No chapters available.